Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease
Inflammatory Bowel Diseases · 2023
DOI: 10.1093/ibd/izac186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2023. Verfasst von Rose Vaughan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Australia. Hauptthemen laut MEDLINE: Crohn Disease, Hyperemia, Inflammatory Bowel Diseases, Colitis, Ulcerative. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Statement on Ethical Conduct in Human Research.
Abstract (Originalsprache)
Background
Mucosal healing improves clinical outcomes in patients with inflammatory bowel disease (IBD) and is associated with higher infliximab trough levels (ITLs). Transmural healing, assessed by intestinal ultrasound (IUS), is emerging as an objective target in Crohn’s disease (CD) and ulcerative colitis (UC). This study explores the correlation between maintenance ITLs and sonographic transmural healing.
Methods
Patients on maintenance infliximab therapy were prospectively enrolled to undergo paired IUS examination and serum ITL. Infliximab trough levels were compared between patients with and without sonographic markers of inflammation using the Mann-Whitney U test.
Results
A prospective cohort of 103 patients (51% male; 79 CD; 24 UC; median duration of disease 8 years) underwent IUS and serum ITL testing. Forty-one percent of CD and 66% of UC patients demonstrated sonographic healing (bowel wall thickening ≤3 mm with no increase in color Doppler signal). Crohn’s disease patients with sonographic healing had higher median ITL compared with those with sonographic inflammation (4.8 μg/mL vs 3.1 μg/mL; P = .049). Additionally, the presence of hyperemia on Doppler was independently associated with lower ITL compared with those without hyperemia (2.1 μg/mL vs 4.2 μg/mL, respectively; P = .003). There was no significant association between ITL and other sonographic markers of inflammation. In UC, lower ITL was associated with hyperemia on Doppler imaging (P = .04). There was no association between ITL and sonographic healing or any other individual sonographic parameter of inflammation.
Conclusions
Lower maintenance infliximab levels are associated with sonographic parameters of inflammation in UC and CD. Further studies are needed to determine whether targeting higher infliximab levels can increase sonographic healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Australia.
- Department of Medicine, The University of Melbourne, Melbourne, Australia.
- Pharmacy, The Royal Melbourne Hospital, Melbourne, Australia.
- Department of Radiology, The Royal Melbourne Hospital and The University of Melbourne, Melbourne, Australia.
ORCID-Profile: Rose Vaughan, Zaid Ardalan, Britt Christensen
Förderung
- National Statement on Ethical Conduct in Human Research
Zitieren
APA
Vaughan, R., Murphy, E., Nalder, M., Gibson, R. N., Ardalan, Z., Boussioutas, A., & Christensen, B. (2023). Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izac186
Vancouver
Vaughan R, Murphy E, Nalder M, Gibson RN, Ardalan Z, Boussioutas A, et al. Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2023. doi:10.1093/ibd/izac186
BibTeX
@article{Vaughan2023,
author = {Vaughan, Rose and Murphy, Elise and Nalder, Michelle and Gibson, Robert N and Ardalan, Zaid and Boussioutas, Alex and Christensen, Britt},
title = {Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease},
journal = {Inflammatory Bowel Diseases},
year = {2023},
doi = {10.1093/ibd/izac186}
}
EUVIMED